[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-333996-105":59,"doc-detail-333996-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","banf1-is-a-novel-prognostic-biomarker-linked-to-immune-infiltration-in-head-and-neck-squamous-cell-carcinoma-original-research","BANF1 is a novel prognostic biomarker linked to immune infiltration in head and neck squamous cell carcinoma - Original Research","","Barrier-to-autointegration factor 1 (BANF1) is a ubiquitously expressed protein overexpressed in multiple cancers, yet its prognostic value in head and neck squamous cell carcinoma (HNSCC) remains unclear. This study analyzes BANF1 expression using GEO and TCGA, applying Cox regression and Kaplan–Meier survival methods, and evaluates associated pathways through KEGG and GO enrichment. It further links BANF1 to drug sensitivity, tumor immune microenvironment metrics, and validates functional effects on HNSCC growth and metastasis in vitro and in vivo.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/banf1-is-a-novel-prognostic-biomarker-linked-to-immune-infiltration-in-head-and-neck-squamous-cell-carcinoma-original-research/333996/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/banf1-is-a-novel-prognostic-biomarker-linked-to-immune-infiltration-in-head-and-neck-squamous-cell-carcinoma-original-research/333996.png","ImageObject",300,407,{"name":92,"@type":93},"River Wang","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the clinical significance of BANF1 in HNSCC prognosis?","Question",{"text":112,"@type":113},"BANF1 is markedly overexpressed in HNSCC and is associated with clinicopathological characteristics. Survival analyses indicate an inverse correlation with patient survival, suggesting BANF1 as a prognostic risk indicator.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were BANF1 prognostic effects assessed in the study?",{"text":117,"@type":113},"The study obtained BANF1 expression data from GEO and TCGA. Cox regression and Kaplan–Meier curves were used to evaluate prognostic potential.",{"name":119,"@type":110,"acceptedAnswer":120},"How does BANF1 relate to immune checkpoint inhibitor therapy and drug sensitivity?",{"text":121,"@type":113},"Higher TIDE scores were observed in the low BANF1 expression group, indicating reduced efficacy of immune checkpoint inhibitor therapy. IC50 comparisons suggested that high BANF1 expression was associated with greater responsiveness to many antitumor treatments.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},333996,1790343494,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":4},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","TYPE Original Research PUBLISHED 08 October 2024  \nDOI 10.3389/fimmu.2024.1465348  \nOPEN ACCESS  \nEDITED BY  \nJingzhou Hu,  \nShanghai Jiao Tong University, China  \nREVIEWED BY  \nElena Niculet,  \nDunarea de Jos University, Romania Zhiquan Huang,  \nSun Yat-sen Memorial Hospital, China  \n*CORRESPONDENCE  \nXinjie Yang  \n [yangxinjie@fmmu.edu.cn](yangxinjie@fmmu.edu.cn)[ ](yangxinjie@fmmu.edu.cn)Jianhua Wei  \n [64265919@qq.com](64265919@qq.com)  \n†These authors have contributed equally to this work  \nRECEIVED 16 July 2024  \nACCEPTED 18 September 2024  \nPUBLISHED 08 October 2024  \nCITATION  \nHe Y, Li H, Li J, Huang J, Liu R, Yao Y, Hu Y, Yang X and Wei J (2024) BANF1 is a novel prognostic biomarker linked to immune inﬁltration in head and neck squamous cell carcinoma.  \nFront. Immunol. 15:1465348 .  \ndoi: 10.3389/fimmu.2024.1465348  \nCOPYRIGHT  \n© 2024 He, Li, Li, Huang, Liu, Yao, Hu, Yang and Wei. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nBANF1 is a novel prognostic biomarker linked to immune inﬁltration in head and necksquamous cell carcinoma  \nYaodong He †, Huan Li †, Jing Li, Junhong Huang, Rong Liu, Yanbing Yao, Yating Hu, Xinjie Yang* and Jianhua Wei*  \nState Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi Clinical Research Center for Oral Diseases, Department of Oral and Maxillofacial Surgery, School of Stomatology, Fourth Military Medical University, Xi ’an, China  \nBackground: Barrier-to-autointegration factor 1 (BANF1) is an abundant and ubiquitously expressed postnatal mammalian protein that is overexpressed in numerous human cancers and can promote cancer cell proliferation. However, the role of BANF1 in prognosis remains unclear in head and neck squamous cell carcinoma (HNSCC) .  \nMethods: BANF1 expression data were obtained from the GEO and TCGA databases. We used Cox regression and Kaplan–Meier curves to assess the prognostic potential of BANF1 . The role of BANF1-related genes was investigated using Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) enrichment analyses. In addition, we explored the link between BANF1, drug sensitivity, and the tumor immune microenvironment. Finally, functional in vitro and in vivo assays were used to explore the effects of BANF1 on tumor growth and metastasis of HNSCC.  \nResults: BANF1 was markedly overexpressed in HNSCC and was correlated with clinicopathological characteristics. According to survival analysis, BANF1 can be inversely correlated with patient survival and can act as a prognostic risk indicator. IC50 values for chemotherapeutic treatments indicated that the group with high BANF1 expression was more responsive to most antitumor treatments. Furthermore, higher TIDE scores were observed in the low BANF1 expression group, indicating a decline in the efﬁcacy of immune checkpoint inhibitor therapy. Functionally, the malignant biological behavior of HNSCC cell lines was inhibited when BANF1 expression was knocked down.  \nConclusion: BANF1 can promote tumor progression in patients with HNSCC. BANF1 shows great promise as a potential biomarker to assess the prognosis.  \nKEYWORDS  \nBANF1, TCGA, immune inﬁltration, head and neck squamous cell carcinoma, prognostic biomarker  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \nIntroduction  \nHead and neck squamous cell carcinoma (HNSCC) is responsible for almost 90% of head and neck malignancies (1) . HNSCC occurs primarily in the oral cavity, nasal cavity, sinuses, pharynx, and larynx (2–4) . HNSCC has an annual ","cbCaiqt2Qcyh3k1u","https://ap.wps.com/l/cbCaiqt2Qcyh3k1u","pdf",28830113,16,"English","# Introduction\n# Methods\n# Results\n# Conclusion","[{\"question\":\"What is the clinical significance of BANF1 in HNSCC prognosis?\",\"answer\":\"BANF1 is markedly overexpressed in HNSCC and is associated with clinicopathological characteristics. Survival analyses indicate an inverse correlation with patient survival, suggesting BANF1 as a prognostic risk indicator.\"},{\"question\":\"How were BANF1 prognostic effects assessed in the study?\",\"answer\":\"The study obtained BANF1 expression data from GEO and TCGA. Cox regression and Kaplan–Meier curves were used to evaluate prognostic potential.\"},{\"question\":\"How does BANF1 relate to immune checkpoint inhibitor therapy and drug sensitivity?\",\"answer\":\"Higher TIDE scores were observed in the low BANF1 expression group, indicating reduced efficacy of immune checkpoint inhibitor therapy. IC50 comparisons suggested that high BANF1 expression was associated with greater responsiveness to many antitumor treatments.\"}]","BANF1 is a novel prognostic biomarker linked to immune infiltration in head and neck squamous cell carcinoma - Original Research | PDF",1790004942]